DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer

Cancer Prevention Research

Volumn 6, Issue 7, 2013, Pages 656-665

  Javier Carmona, F ^a   Azuara, Daniel ^b   Berenguer Llergo, Antonio ^c,h   Fernández, Agustin F ^a,i   Biondo, Sebastiano ^e,f   De Oca, Javier ^e,f   Rodriguez Moranta, Francisco ^c   Salazar, Ramón ^b,h   Villanueva, Alberto ^b   Fraga, Mario F ^i,j   Guardiola, Jordi ^c   Capellá, Gabriel ^b,d   Esteller, Manel ^a,f,g   Moreno, Victor ^c,f,h  

^a Cancer Epigenetics and Biology Program (PEBC)   (United States)

^b Translational Research Laboratory   (United States)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d Catalan Institute of Oncology (ICO IDIBELL)   (Spain)

^e Colorectal Unit ^*  (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

^g INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^h CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

ⁱ DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^j CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; AGTR1 PROTEIN, HUMAN; ANGIOTENSIN 1 RECEPTOR; DNA; NERVE PROTEIN; SIGNAL PEPTIDE; SLIT HOMOLOG 2 PROTEIN; TUMOR MARKER; WNT2 PROTEIN; WNT2 PROTEIN, HUMAN;

ADULT; AGED; AGTR1 GENE; ARTICLE; COLORECTAL CANCER; COMPUTER MODEL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA EXTRACTION; DNA METHYLATION; DNA MICROARRAY; DYSPLASIA; EARLY DIAGNOSIS; ENTERITIS; EPHA7 GENE; EYA4 GENE; FECES ANALYSIS; FEMALE; FOLLOW UP; GENE; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE ENDOSCOPY; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; NUCLEOTIDE SEQUENCE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; SENSITIVITY AND SPECIFICITY; SEPT9 GENE; SLIT2 GENE; TUMOR BIOPSY; VALIDATION STUDY; VIM GENE; WNT2 GENE; CANCER GRADING; CANCER STAGING; CASE CONTROL STUDY; CHEMISTRY; COLON; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; FECES; GENETICS; INFLAMMATORY BOWEL DISEASES; METABOLISM; MIDDLE AGED; PROGNOSIS; RECTUM;

AGED; CASE-CONTROL STUDIES; COLON; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA, NEOPLASM; FECES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NERVE TISSUE PROTEINS; PROGNOSIS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECTUM; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; WNT2 PROTEIN;

EID: 84880063991     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0501     Document Type: Article

References (48)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008:GLOBOCAN2008. Int J Cancer 2010;127:2893-917.
2. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
3. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012;366:2345-57.
4. Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59:62-8.
5. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697-706.
6. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008;135:1079-99.
7. Ahlquist DA. Molecular detection of colorectal neoplasia. Gastroenterology 2010;138:2127-39.
8. Berger BM, Ahlquist DA. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Pathology 2012;44:80-8.
9. Zou H, Taylor WR, Harrington JJ, Hussain FT, Cao X, Loprinzi CL, et al. High detection rates of colorectal neoplasia by stoolDNAtesting with a novel digital melt curve assay. Gastroenterology 2009;136:459-70.
10. Matsubara N. Epigenetic regulation and colorectal cancer. Dis Colon Rectum 2012;55:96-104.
11. Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev 2011;8:686-700.
12. Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, et al. Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clin Colorectal Cancer 2010;9:168-76.
13. Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005;128:192-206.
14. Ahlquist DA, Zou H, Domanico M, Mahoney DW, Yab TC, Taylor WR, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012;142:248-56; quiz e25-6.
15. Zou H, Harrington JJ, Shire AM, Rego RL, Wang L, Campbell ME, et al. Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev 2007;16: 2686-96.
16. Glockner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res 2009; 69:4691-9.
17. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, Wu B, et al. Highthroughput DNA methylation profiling using universal bead arrays. Genome Res 2006;16:383-93.
18. Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005;97: 1124-32.
19. Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008;54:414-23.
20. Grutzmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD, et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS ONE 2008;3: e3759.
21. deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 2009;55:1337-46.
22. Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, Blanco I, et al. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res 2006;12: 2101-8.
23. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002;30:207-10.
24. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, et al. NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res 2009;37:D885-90.
25. Kim YH, Lee HC, Kim SY, Yeom YI, Ryu KJ, Min BH, et al. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations. Ann Surg Oncol 2011;18:2338-47.
26. Kibriya MG, Raza M, Jasmine F, Roy S, Paul-Brutus R, Rahaman R, et al. A genome-wide DNA methylation study in colorectal carcinoma. BMC Med Genomics 2011;4:50.
27. Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, Shen R, et al. Genome-wide DNA methylation profiling using Infinium(R) assay. Epigenomics 2009;1:177-200.
28. Puig P, Urgell E, Capella G, Villanueva A, Grau M, Sancho FJ, et al. Improved detection of K-ras codon 12 mutations in fecal exfoliated cells. Lab Invest 1999;79:617-8.
29. Fan JB, Oliphant A, Shen R, Kermani BG, Garcia F, GundersonKL, et al. Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol 2003;68:69-78.
30. Canty A, Ripley B. boot: Bootstrap R (S-Plus) Functions. R package version 1.3-2. Vienna, Austria: R Foundation for Statistical Computing; 2011.
31. Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: Visualizing the performance of scoring classifiers. R package version 1.0-4. Vienna, Austria: R Foundation for Statistical Computing; 2009.
32. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
33. Ned RM, Melillo S, Marrone M. Fecal DNA testing for colorectal cancer screening: the ColoSure- test. PLoS Curr 2011;3:RRN1220.
34. Kamimae S, Yamamoto E, Yamano HO, Nojima M, Suzuki H, Ashida M, et al. Epigenetic alteration of DNA in mucosal wash fluid predicts invasiveness of colorectal tumors. Cancer Prev Res 2011;4:674-83.
35. Luo YX, Chen DK, Song SX, Wang L, Wang JP. Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis. Int J Clin Prac 2011;65:1313-20.
36. Bosch LJ, Oort FA, Neerincx M, Khalid-de Bakker CA, Terhaar sive Droste JS, Melotte V, et al. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT. Cancer Prev Res 2012;5:464-72.
37. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 1994;35:950-4.
38. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323:1228-33.
39. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-51.
40. Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:314-21.
41. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol 2004;287:G7-17.
42. Fujii S, Tominaga K, Kitajima K, Takeda J, Kusaka T, Fujita M, et al. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis. Gut 2005;54:1287-92.
43. Garrity-Park MM, Loftus EV Jr, Sandborn WJ, Bryant SC, Smyrk TC. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer. Am J Gastroenterol 2010;105:1610-9.
44. Wang FY, Arisawa T, Tahara T, Takahama K, Watanabe M, Hirata I, et al. Aberrant DNA methylation in ulcerative colitis without neoplasia. Hepatogastroenterology 2008;55:62-5.
45. Nakajima T, Enomoto S, Yamashita S, Ando T, Nakanishi Y, Nakazawa K, et al. Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication. J Gastroenterol 2010; 45:37-44.
46. Saito S, Kato J, Hiraoka S, Horii J, Suzuki H, Higashi R, et al. DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status. Inflamm Bowel Dis 2011;17:1955-65.
47. Azuara D, Rodriguez-Moranta F, de Oca J, Sanjuan X, Guardiola J, Lobaton T, et al. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients. Inflamm Bowel Dis 2013;19:165-73.
48. Kisiel JB, Yab TC, Taylor WR, Chari ST, Petersen GM, Mahoney DW, et al. Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates. Cancer 2012;118:2623-31.